Inventiva (IVA) Cash from Financing Activities (2019 - 2022)

Inventiva (IVA) recorded quarterly Cash from Financing Activities of $14.2 million in Q4 2022, down 2.22% quarter-over-quarter from $14.6 million in Q3 2022, and up 40038.88% on a YoY basis from N/an in Q4 2021.

Inventiva (IVA) Cash from Financing Activities (2019 - 2022) Analysis & Trends

Inventiva's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $14.2 million for Q4 2022.

  • In Q4 2022, Cash from Financing Activities rose 40038.88% year-over-year to $14.2 million; the TTM figure through Dec 2022 stood at $28.9 million (down 1.79% YoY), while the FY2025 annual figure was $280.9 million, up 80.53% from the prior year.
  • Cash from Financing Activities was $14.2 million for Q4 2022 at Inventiva, down from $14.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $29.3 million in Q4 2020 to a low of -$132826.5 in Q4 2019.
  • Historically, Cash from Financing Activities has averaged $9.5 million across 4 years, with a median of $11.0 million in 2020.
  • The sharpest annual moves came in 2021 and 2022: Cash from Financing Activities plunged 100.12% in 2021, then soared 40038.88% in 2022.
  • A 4-year view of Cash from Financing Activities shows it stood at -$132826.5 in 2019, then surged by 22187.97% to $29.3 million in 2020, then sank by 99.88% to $35463.1 in 2021, then jumped by 40038.88% to $14.2 million in 2022.
  • The last three Cash from Financing Activities figures came in at $14.2 million (Q4 2022), $14.6 million (Q3 2022), and $35463.1 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 7.00 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 53,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -538.80 Mn
9 Abivax 90.15 Bn 90.15 Bn - 85,464.43
10 Inventiva 8.64 Mn -260.09 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 14.23 Mn
Dec 31, 2022 14.23 Mn
Sep 22, 2022 14.56 Mn
Sep 22, 2022 14.56 Mn
Dec 31, 2021 35,463.10
Dec 31, 2021 35,463.10
Jun 30, 2021 56,600.76
Jun 30, 2021 56,600.76
Mar 31, 2021 -19,299.78
Mar 31, 2021 -19,299.78
Dec 31, 2020 29.34 Mn
Dec 31, 2020 29.34 Mn
Jun 30, 2020 10.99 Mn
Jun 30, 2020 10.99 Mn
Mar 31, 2020 16.15 Mn
Mar 31, 2020 16.15 Mn
Dec 31, 2019 -132,826.52
Dec 31, 2019 -132,826.52